Navigation Links
Partnerships Effective Communicators of Cancer Advances
Date:5/16/2008

Treatment guidelines quickly disseminated to community physicians, audit finds

FRIDAY, May 16 (HealthDay News) -- Partnerships between major academic cancer centers and community hospitals are a quick and effective way to spread cancer treatment advances, say researchers at Fox Chase Cancer Center in Philadelphia.

Most new cancer treatments are created at major academic centers and most cancer care is provided at community hospitals, noted the researchers, who conducted a quality control audit of hospitals associated with Fox Chase, a U.S. National Cancer Institute-designated Comprehensive Cancer Center.

The 26 hospitals that are part of the Fox Chase Partners Program have access to the most recent cancer treatment guidelines developed by Fox Chase and other member institutions of the National Comprehensive Cancer Network (NCCN).

"When research leads to significant changes in treatment, it can take years before community oncologists are able to fully adopt the new guidelines. What's unique about the (Fox Chase) Partners program is the timely transition of advances. The audit we conducted shows that our Partner physicians are highly compliant in incorporating recent advances in cancer treatment," Margaret O'Grady, director of care management and clinical operations of Fox Chase Cancer Partners, said in a prepared statement.

She and her colleagues reviewed the medical charts of 124 patients, age 65 or older, treated for stage III colon cancer at Partner hospitals between 2003 and 2006, and found high compliance with NCCN treatment guidelines, including obtaining a minimum of 12 lymph nodes at surgery, and the addition of oxaliplatin to adjuvant chemotherapy.

Almost all patients (123) received adjuvant chemotherapy, although only 76 (61 percent) received oxaliplatin, a chemotherapy agent shown to extend survival in this group of patients.

"At first glance, this number looked low, but as we probed further, we found that all but 11 patients who didn't receive oxaliplatin had documented co-morbidities or other concerns that precluded them from receiving this treatment," O'Grady said.

The audit also found that 74 percent of patients had at least 12 lymph nodes retrieved, which is critically important to cancer treatment planning.

Nearly all the patients (93 percent) received appropriate surveillance with history and physical exams at suggested intervals and routine CEA testing. Abdominal and pelvic surveillance CT was performed in 78 percent of patients.

"We found a drop-off in compliance (49 percent) regarding the documentation of discussions between the doctor and patient about age and life expectancy in relation to adjuvant chemotherapy," O'Grady said. "This discussion is important and informs decision-making."

More information

The U.S. National Cancer Institute has more about cancer therapy.



-- Robert Preidt



SOURCE: Fox Chase Cancer Center, news release, May 15, 2008


'/>"/>
Copyright©2008 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. Chiltern Will Sponsor and Present at the 17th Annual Partnerships With CROs Meeting in Las Vegas, April 14 - 16, 2008.
2. Northwestern Memorial Hospital, CAPS, and p4ps Host Consumer Forum to Advance Partnerships to Improve Healthcare Patient Safety
3. Partnerships Report Highlights How Blue Cross Blue Shield of Michigan, Physicians and Hospitals Are Working to Save Lives, Improve Care, Reduce Costs
4. Snap Fitness Launches Partnerships with Leading Online Health & Fitness Companies
5. On World AIDS Day, Keeping the Promise to Stop AIDS Through the Power of Partnerships
6. First-Ever Collaborative Summit on Breast Cancer Research Targets New Partnerships and Collaborative Solutions
7. Chiltern to Participate at the Partnerships in Clinical Trials Conference in Amsterdam
8. MGT Capital Investments Announces New Commercial Partnerships for Subsidiary Company Medicexchange PLC
9. Ingenious Med Forms Multiple Billing Company Partnerships to Market Inpatient Practice Management Solutions
10. Study shows that administering calcium and magnesium effectively reduces neurological sensitivity
11. Partnership of academic centers and community hospitals effective model for disseminating advances
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/22/2017)... Freedom, PA (PRWEB) , ... April 22, 2017 ... ... healthcare experience to his role as Vice President of Sales and Business Development ... of key GPO/IDN business partner engagements, business development, and strategic planning for the ...
(Date:4/21/2017)... ... April 21, 2017 , ... The staff at Palm Beach Face is proud to announce ... the 2017 London Marathon. Set to take place on April 23rd, the London Marathon has ... Schwartz will run as part of team EMPOWER, raising money for the international charity, Smile ...
(Date:4/21/2017)... Wis. (PRWEB) , ... April 21, 2017 , ... ... today announced that its B-595 and B-7569 vinyl label materials ... identification and warning labels are tested to remain intact and legible, for use on ...
(Date:4/21/2017)... ... April 21, 2017 , ... The Patient Advocacy Community of ... with the 2017 Ruth Ravich Patient Advocacy Award in recognition of her ... was honored with the award at The Beryl Institute’s annual Patient Experience Conference ...
(Date:4/21/2017)... , ... April 21, 2017 , ... ... weeklong campaign, AWARE: A Week of Addiction and Recovery Education, from April 24 ... treating and preventing substance use disorders. , The mission of AWARE is ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... DIEGO , April 19, 2017  Sorrento ... an antibody-centric, clinical-stage biopharmaceutical company developing new treatments ... announced the closing of its previously announced underwritten ... stock at a public offering price of $2.00 ... and estimated offering expenses payable by Sorrento.  The ...
(Date:4/19/2017)... , April 19, 2017  New research provides evidence that ... Parkinson,s, according to a study released today that will be ... Meeting in Boston , April 22 ... the treatment of Parkinson,s disease, the oral drug levodopa has ... and longevity. But as the disease progresses, the effects of ...
(Date:4/19/2017)... OAKS, Calif. , April 19, 2017 /PRNewswire/ ... industrial buildings it is developing at Conejo Spectrum ... , to Atara Biotherapeutics, Inc. , ... with severe and life-threatening diseases that have been ... on allogeneic T-cell therapies for cancer, autoimmune and ...
Breaking Medicine Technology: